Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.085 USD | -1.64% | -0.29% | -43.44% |
07/05 | Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value | CI |
02/05 | Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.44% | 738M | |
+3.33% | 108B | |
+10.69% | 104B | |
+1.28% | 22.33B | |
-12.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.84% | 17.64B | |
+4.88% | 14.05B | |
+34.51% | 12.51B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- HC Wainwright Adjusts Price Target on Aurinia Pharmaceuticals to $14 From $26, Maintains Buy Rating